These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18561522)

  • 1. Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy.
    Kozdag G; Ciftci E; Ural D; Sahin T; Selekler M; Agacdiken A; Demirci A; Komsuoglu S; Komsuoglu B
    Vasc Health Risk Manag; 2008; 4(2):463-9. PubMed ID: 18561522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent cerebral infarction in patients with dilated cardiomyopathy: echocardiographic correlates.
    Kozdag G; Ciftci E; Vural A; Selekler M; Sahin T; Ural D; Kahraman G; Agacdiken A; Demirci A; Komsuoglu S; Komsuoglu B; Fici F
    Int J Cardiol; 2006 Mar; 107(3):376-81. PubMed ID: 15913815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major depressive disorder in chronic heart failure patients: Does silent cerebral infarction cause major depressive disorder in this patient population?
    Kozdağ G; Yaluğ İ; İnan N; Ertaş G; Selekler M; Kutlu H; Kutlu A; Emre E; Çetin M; Ural D
    Turk Kardiyol Dern Ars; 2015 Sep; 43(6):505-12. PubMed ID: 26363742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy.
    Tompkins BA; Rieger AC; Florea V; Banerjee MN; Natsumeda M; Nigh ED; Landin AM; Rodriguez GM; Hatzistergos KE; Schulman IH; Hare JM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy.
    Berger RD; Kasper EK; Baughman KL; Marban E; Calkins H; Tomaselli GF
    Circulation; 1997 Sep; 96(5):1557-65. PubMed ID: 9315547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dobutamine stress echocardiography in distinguishing ischemic from nonischemic dilated cardiomyopathy].
    Miloradović V; Irić-Cupić V; Popović AD
    Med Pregl; 2005; 58(11-12):541-7. PubMed ID: 16673855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.
    Rossi A; Dini FL; Faggiano P; Agricola E; Cicoira M; Frattini S; Simioniuc A; Gullace M; Ghio S; Enriquez-Sarano M; Temporelli PL
    Heart; 2011 Oct; 97(20):1675-80. PubMed ID: 21807656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Doppler echocardiographic identification of ischemic etiology in patients with dilated cardiomyopathy.
    Plewka M; Krzemińska-Pakuła M; Drozdz J; Ciesielczyk M; Wierzbowska K; Kasprzak JD
    Scand Cardiovasc J; 2005 Dec; 39(6):334-41. PubMed ID: 16352485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure.
    Zemljic G; Poglajen G; Sever M; Cukjati M; Frljak S; Androcec V; Cernelc P; Haddad F; Vrtovec B
    J Card Fail; 2017 Feb; 23(2):153-160. PubMed ID: 27523610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: Ischemic heart failure versus non-ischemic dilated cardiomyopathy.
    Bakal RB; Hatipoglu S; Kahveci G; Omaygenc MO; Unkun T; Akgun T; Sahin M; Elveran A; Ozveren O; Ozdemir N
    Cardiol J; 2014; 21(1):67-75. PubMed ID: 23799554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study.
    Santagata P; Rigo F; Gherardi S; Pratali L; Drozdz J; Varga A; Picano E
    Int J Cardiol; 2005 Oct; 105(1):46-52. PubMed ID: 16207544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
    D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling.
    Lapu-Bula R; Robert A; De Kock M; D'Hondt AM; Detry JM; Melin JA; Vanoverschelde JL
    Am J Cardiol; 1998 Sep; 82(6):779-85. PubMed ID: 9761090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function has an effect on cardiovascular mortality in patients with dilated cardiomyopathy.
    Ertaş G; Kozdağ G; Emre E; Vural A; Akbulut T; Ural D; Göktekin Ö
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):554-8. PubMed ID: 22801072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T; Tatli E; Yuksel M
    Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease.
    Pepi M; Agostoni P; Marenzi G; Dorai E; Guazzi M; Lauri G; Maltagliati A; Guazzi M
    Eur J Heart Fail; 1999 Jun; 1(2):161-7. PubMed ID: 10937926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.